Carol Brosgart joins Alios as CMO
This article was originally published in Scrip
Executive Summary
Alios BioPharma, a San Francisco-based biotech company focused on the development of medicines to treat viral diseases by activating pathways in the innate immune system, has appointed Dr Carol Brosgart chief medical officer. Dr Brosgart joins from Children's Hospital & Research Center in California, where she was senior vice-president and chief medical officer. Before that, she gained more than 10 years' pharmaceutical industry experience at Gilead Sciences, where she held a number of senior management roles.